PLEASE REFER TO ANZFA’S GUIDE TO APPLICATIONS AND ...

A number of studies were conducted to examine the potential toxicity of ISP and to determine whether ISP is likely to act as an allergen in humans. The results of a 13-week sub-chronic rat feeding study using a concentrated form of the ISP preparation from yeast showed no treatment related adverse effects at a range of doses up to 580 mg/kg/day ... ................
................